5-Amino-1MQ: Research Guide to the NNMT Inhibitor

For laboratory research use only.

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor used in metabolic research. It is not a peptide and should not be filed among GHRPs or copper peptides simply because it shares a storefront category.

Chemical identity

PubChem lists 1-methylquinolin-1-ium-5-amine as CID 950107 with formula C10H11N2+ and molecular weight about 159.2 for the cation (PubChem CID 950107). Counter-ions and salt forms on commercial lots matter for mass and analytical identity; LC–MS methods have been developed specifically for quantifying 5-amino-1-methylquinolinium in rat plasma (LC-MS/MS assay).

NNMT biology and inhibitor findings

NNMT methylates nicotinamide using S-adenosylmethionine, linking NAD+ salvage chemistry to methylation potential. Neelakantan and colleagues described selective, membrane-permeable small-molecule NNMT inhibitors—including the 5-amino-1-methylquinolinium chemotype—that reduced 1-methylnicotinamide, altered NAD+/SAM-related readouts, and reversed high-fat-diet–induced obesity phenotypes in mice in the reported study (Neelakantan et al., 2018). Follow-on work combining calorie restriction with NNMT inhibition examined microbiome and metabolic outcomes in diet-induced obese mice (NNMT inhibition + diet study).

What not to infer

Pathway cartoons that place NNMT next to NAD+ biosynthesis do not make 5-Amino-1MQ interchangeable with NAD+, NMN, or nicotinamide. Mouse metabolic phenotypes are not established clinical benefit. Confirm the salt form on the label before comparing lots or matching a methods paper.

Sources

Shopping Cart
Scroll to Top